Pancreatic Cancer Research

ResearcherDartmouth CollegeNo recent work listed

Sophie J. Deharvengt

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0766-2464; OpenAlex author ID A5031645313. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers

Papers 3

  1. PV1 down-regulation via shRNA inhibits the growth of pancreatic adenocarcinoma xenografts. Co-author DOI 10.1111/j.1582-4934.2012.01587.x↗
  2. Concomitant targeting of EGF receptor, TGF-beta and SRC points to a novel therapeutic approach in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0039684↗
  3. Aberrant expressions of AP-2α splice variants in pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e31821f2715↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Murray Korc · 2 shared papers, 2011–2012 · strength 0.09
  2. Catherine Carrière · 2 shared papers, 2011–2012 · strength 0.07
  3. Radu Virgil Stan · 1 shared paper, 2012 · strength 0.03
  4. Daniel S. Longnecker · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.